Get started
Author

Salwa Lin

ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype
2021 · Helen Sheldon, John Alexander, et al. · International Journal of Molecular Sciences · 21
PDF
ELTD1 is present in extracellular vesicles derived from endothelial cells as a cleaved extracellular domain which induces in vivo angiogenesis
2022 · Helen Sheldon, Wei Zhang, et al. · Journal of Extracellular Biology · 9
PDF
SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al. · Cancer Research · 1
From Delivery to Design: Site-Specific Genome Engineering for Next-Generation CAR T-Cell Therapy
2026 · Hala Aldahshan, Abeer Al-Hubaysh, et al. · Biomedicines
Figure 1 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Figure 2 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Figure S2 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Table S2 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Table S3 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Table S4 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Figure S4 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Data from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Figure 6 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Figure 3 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Figure S3 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Figure 4 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Figure S1 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Figure 5 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
Table S1 from SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian M. Ortmann, Tekle Pauzaite, et al.
SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
2026 · Brian Ortmann, Tekle Pauzaite, et al. · Newcastle University ePrints (Newcastle Univesity)
The Vascular Metastatic Niche Changes in Time and Space
2025 · Salwa Lin, Badran Elshenawy, et al. · SSRN Electronic Journal
Works count: 22
Citation count: 31
H-index: 2
I10-index: 1
Year
Topic
Type